IsYourChild Nearsighted?

Ifyourchild has myopia (nearsightedness) he/she mayqualifyforthe CHAPERONEClinical Study,nowbeing offered at select centers throughout the US.The studyis testing 2 different strengths ofmicrodosed atropine eye solution forslowing the progression ofmyopia in children.

Study-related care free ofcharge • Compensation fortime and travel

Initial Eligibility Criteria

4 Aged 3 years - 12 years, with a diagnosis of myopia (nearsightedness)

4 Glasses or contact lens prescription of -1.00 to -6.00 diopters

4 Able and willing to use medication administered as a spray mist to each eye once daily before bedtime for a period of 4 years

4 No previous use ofothermyopia drug therapies (atropine, pirenzepene, orothertopicalanti-muscarinic drug)

Caution: New Drug - Limited by Federal (United States) Lawto InvestigationalUse

This study is not sponsored by Upper Arlington Schools.